Cleared Traditional

K110077 - NEUCOLONCARE

K110077 is an FDA 510(k) clearance for NEUCOLONCARE, manufactured by Neusoft Medical Systems Co., Ltd.. The device is a Class 2 Radiology device with product code LLZ cleared through the Traditional 510(k) pathway after a 17-day FDA review.

K110077 · Neusoft Medical Systems Co., Ltd. · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 2011
Decision
17d
Days
Class 2
Risk

K110077 is an FDA 510(k) clearance for the NEUCOLONCARE. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Neusoft Medical Systems Co., Ltd. (Shenyang, Liaoning, CN). The FDA issued a Cleared decision on January 28, 2011 after a review of 17 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Neusoft Medical Systems Co., Ltd. devices

FDA 510(k) Submission Details - K110077

510(k) Number K110077 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received January 11, 2011
Decision Date January 28, 2011
Days to Decision 17 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
90d faster than avg
Panel avg: 107d · This submission: 17d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

LLZ Device Classification - Class 2, Special Controls

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Consultant

Underwriters Laboratories, Inc.
MARC M MOUSER

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1192
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K110077.
ACIES
K101842 · Konica Minolta Medical & Graphic, Inc. · Feb 2011
SECURVIEW DX DIAGNOSTIC WORKSTATION
K103385 · Hologic, Inc. · Feb 2011
SYNAPSE 3D CARDIAC TOOLS
K103465 · Fujifilm Medical Systems U.S.A, Inc. · Jan 2011
Q-STATION
K103815 · Philips Ultrasound, Inc. · Jan 2011
TRIANA, PICTURE ARCHIVING AND COMMUNICATIONS SYSTEM
K103182 · Genoray Co., Ltd. · Jan 2011
20.1 INCH (51 CM) COLOR LCD MONITOR CCL208 (CDL2013A)
K092728 · Totoku Electric Co., Ltd. · Nov 2010